EXPLORE!

Management of Adult MCD

  819 Views

Dr Raja Ramachandran, Chandigarh    27 December 2018

  • Adult minimal change disease (MCD) presents with nephrotic syndrome (NS).
  • Steroid responsiveness is seen in 80% of the cases (1 mg/kg).
  • Pulse steroids followed by TAC or MM-Na with LD steroids are steroid limiting options in adult MCD.
  • A relapsing disease is seen in one-third-50% cases.
  • Rituximab is cost-effective and has a favorable adverse effect profile in managing steroid-dependent (SD) or frequently relapsing (FR) disease.
  • Steroid-resistant MCD is unsampled non-MCD disease.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.